2018 Research Annual Report
Molecular Cardiovascular Biology

Molecular Cardiovascular Biology

Featured Research

Gβγ-GRK2 Inhibitor Slows Heart Failure Symptoms The small-molecule compound gallein helps reduce major symptoms of heart failure in mice by blocking signals sent by a protein that helps regulate the heart’s response to adrenaline—a discovery that eventually may shift treatment approaches for one of the nation’s leading causes of death.

Read Featured Research

Division Summary

Research and Training Details
Faculty 8
Research Fellows and Post Docs 20
Research Graduate Students 14
Total Annual Grant Award Dollars $6,443,617